http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CL-2011002091-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7df32ca28bf405353fc751fd0ffb122a
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2121-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0031
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-79
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-573
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0046
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0031
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-10
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-573
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-40
filingDate 2011-08-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2637a460c6ccf76ab792308715af9b29
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a5a043ab4b506d8552cca59a27bd0f0c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_57448b1e1552dd32f10c641deff13b96
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_64effc2dbf050c1058db3d9b32715fb8
publicationDate 2012-04-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CL-2011002091-A1
titleOfInvention Preparation comprising: a. 0.01-5.0% povidone iodine and b. 0.01-2.0% of a steroid selected from loteprednol and rimexolone, their esters or salts thereof; Useful for treating otitis.
abstract Method for treating a mammal with an otic infection comprising the application of a composition comprising povidone iodine 0.01% -5.0% and a steroid 0.01% -2.0%, selected from dexamethasone, flurometalone, lotoprendol, medrisone, prednisolone, difluprednate, rimexolone and hydrocortisone.
priorityDate 2009-02-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9865442
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419569253
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419590963
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID443936
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5311412
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419590874
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448241444
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID410087
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5755
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419477255
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419492800
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5743
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID247839
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5754
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419506586
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419479648

Total number of triples: 46.